For this Abbott executive, solving problems isn ’ t enough: ‘ We need to add value ’

As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore. What was your path like from electrical engineering to Abbott’s cardiac arrhythmia business? Pederson: As an engineer, I’ve always been drawn to how technology can evolve and re-shape entire industries. In particular, health technology can fundamentally change the lives of people battling complex health conditions. Seeing new therapies or diagnostic tools go from the earliest stages of research and design and evolving into the products physicians and hospitals deploy to positively change the course of someone’s life never stops inspiring me. After receiving my MBA, I was in Minneapolis-St. Paul looking for a job that would bring me back into cutting-edge technology. Within Minneapolis-St. Paul, the foremost industry is medtech. From startups to some of the largest health tech companies in the world – Minneapolis-St. Paul is home to so many innovative companies. In 1992 I joined Guidant Corp., which at the time was a leader in cardiac pacing technology. From there I held various leadership roles and remained with the company until it was acquired by Boston Scientific, which I joined in 2006. From there my experience continued to expand beyond cardiac rhythm mana...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Wall Street Beat Abbott devicetalksminnesota Source Type: news